5-HT1F Receptor Agonists in Acute Migraine Treatment: A Hypothesis (Q34649017)

3 August 2017

1 reference

title

5-HT1F receptor agonists in acute migraine treatment: a hypothesis (English)

1 reference

3 August 2017

5-HT1F Receptor Agonists in Acute Migraine Treatment: A Hypothesis (English)

1 reference

https://api.crossref.org/works/10.1046/J.1468-2982.2003.00525.X

14 March 2024

1 reference

N. M. Ramadan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:14510923

14 March 2024

V. Skljarevski

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:14510923

14 March 2024

L. A. Phebus

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:14510923

14 March 2024

K. W. Johnson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:14510923

14 March 2024

language of work or name

English

0 references

publication date

1 October 2003

1 reference

full work available at URL

3 August 2017

http://journals.sagepub.com/doi/pdf/10.1046/j.1468-2982.2003.00525.x

1 reference

https://api.crossref.org/works/10.1046/J.1468-2982.2003.00525.X

http://journals.sagepub.com/doi/full-xml/10.1046/j.1468-2982.2003.00525.x

14 March 2024

1 reference

https://api.crossref.org/works/10.1046/J.1468-2982.2003.00525.X

14 March 2024

1 reference

3 August 2017

volume

23

1 reference

3 August 2017

issue

8

1 reference

3 August 2017

page(s)

776-785

1 reference

GR43175, a selective agonist for the 5-HT1-like receptor in dog isolated saphenous vein

3 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1046/J.1468-2982.2003.00525.X

The neurobiology of vascular head pain

14 March 2024

2

1 reference

https://api.crossref.org/works/10.1046/J.1468-2982.2003.00525.X

The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura mater

14 March 2024

4

1 reference

https://api.crossref.org/works/10.1046/J.1468-2982.2003.00525.X

Pharmacological aspects of experimental headache models in relation to acute antimigraine therapy

14 March 2024

5

1 reference

https://api.crossref.org/works/10.1046/J.1468-2982.2003.00525.X

5-HT1F receptor agonists inhibit neurogenic dural inflammation in guinea pigs

14 March 2024

6

1 reference

https://api.crossref.org/works/10.1046/J.1468-2982.2003.00525.X

Sumatriptan (GR 43175) interacts selectively with 5-HT1B and 5-HT1D binding sites

14 March 2024

7

1 reference

https://api.crossref.org/works/10.1046/J.1468-2982.2003.00525.X

Anti-migraine drugs in development: advances in serotonin receptor pharmacology

14 March 2024

8

1 reference

https://api.crossref.org/works/10.1046/J.1468-2982.2003.00525.X

Human serotonin 1D receptor is encoded by a subfamily of two distinct genes: 5-HT1D alpha and 5-HT1D beta

14 March 2024

10

1 reference

https://api.crossref.org/works/10.1046/J.1468-2982.2003.00525.X

Pathophysiology of migraine--new insights.

14 March 2024

11

1 reference

https://api.crossref.org/works/10.1046/J.1468-2982.2003.00525.X

Cloning of another human serotonin receptor (5-HT1F): a fifth 5-HT1 receptor subtype coupled to the inhibition of adenylate cyclase

14 March 2024

12

1 reference

https://api.crossref.org/works/10.1046/J.1468-2982.2003.00525.X

Vasoconstriction in human isolated middle meningeal arteries: determining the contribution of 5-HT1B- and 5-HT1F-receptor activation

14 March 2024

13

1 reference

https://api.crossref.org/works/10.1046/J.1468-2982.2003.00525.X

Migraine therapy: relationship between serotonergic contractile receptors in canine and rabbit saphenous veins to human cerebral and coronary arteries

14 March 2024

14

1 reference

https://api.crossref.org/works/10.1046/J.1468-2982.2003.00525.X

No contractile effect for 5-HT1D and 5-HT1F receptor agonists in human and bovine cerebral arteries: similarity with human coronary artery

14 March 2024

16

1 reference

https://api.crossref.org/works/10.1046/J.1468-2982.2003.00525.X

Localization of 5-HT1B, 5-HT1D alpha, 5-HT1E and 5-HT1F receptor messenger RNA in rodent and primate brain

14 March 2024

17

1 reference

https://api.crossref.org/works/10.1046/J.1468-2982.2003.00525.X

[3H]sumatriptan labels both 5-HT1D and 5-HT1F receptor binding sites in the guinea pig brain: an autoradiographic study

14 March 2024

18

1 reference

https://api.crossref.org/works/10.1046/J.1468-2982.2003.00525.X

[3H]Sumatriptan binding sites in human brain: regional-dependent labelling of 5-HT1D and 5-HT1F receptors

14 March 2024

19

1 reference

https://api.crossref.org/works/10.1046/J.1468-2982.2003.00525.X

Cloning and Characterization of The Guinea Pig 5-HT 1F Receptor Subtype: a Comparison of the Pharmacological Profile to the Human Species Homolog

14 March 2024

20

1 reference

https://api.crossref.org/works/10.1046/J.1468-2982.2003.00525.X

Multiple microvascular and astroglial 5-hydroxytryptamine receptor subtypes in human brain: molecular and pharmacologic characterization

14 March 2024

21

1 reference

https://api.crossref.org/works/10.1046/J.1468-2982.2003.00525.X

Co-localization of 5-HT(1B/1D/1F) receptors and glutamate in trigeminal ganglia in rats

14 March 2024

22

1 reference

https://api.crossref.org/works/10.1046/J.1468-2982.2003.00525.X

Plasma levels of neuroexcitatory amino acids in patients with migraine or tension headache

14 March 2024

23

1 reference

https://api.crossref.org/works/10.1046/J.1468-2982.2003.00525.X

Both 5-HT1B and 5-HT1F receptors modulate c-fos expression within rat trigeminal nucleus caudalis

14 March 2024

25

1 reference

https://api.crossref.org/works/10.1046/J.1468-2982.2003.00525.X

Possible antimigraine mechanisms of action of the 5HT1F receptor agonist LY334370.

14 March 2024

26

1 reference

https://api.crossref.org/works/10.1046/J.1468-2982.2003.00525.X

Contractile responses to sumatriptan and ergotamine in the rabbit saphenous vein: effect of selective 5-HT(1F) receptor agonists and PGF(2alpha).

14 March 2024

28

1 reference

https://api.crossref.org/works/10.1046/J.1468-2982.2003.00525.X

Variable participation of 5-HT1-like receptors and 5-HT2 receptors in serotonin-induced contraction of human isolated coronary arteries. 5-HT1-like receptors resemble cloned 5-HT1D beta receptors.

14 March 2024

29

1 reference

https://api.crossref.org/works/10.1046/J.1468-2982.2003.00525.X

Neurogenically mediated leakage of plasma protein occurs from blood vessels in dura mater but not brain

14 March 2024

30

1 reference

https://api.crossref.org/works/10.1046/J.1468-2982.2003.00525.X

Functional profile of almotriptan in animal models predictive of antimigraine activity

14 March 2024

32

1 reference

https://api.crossref.org/works/10.1046/J.1468-2982.2003.00525.X

The in vivo pharmacological profile of eletriptan (UK-116,044): a potent and novel 5-HT(1B/1D) receptor agonist

14 March 2024

33

1 reference

https://api.crossref.org/works/10.1046/J.1468-2982.2003.00525.X

Differential Effects of 5-HT 1B/1D Receptor Agonists on Neurogenic Dural Plasma Extravasation and Vasodilation in Anaesthetized Rats

14 March 2024

34

1 reference

https://api.crossref.org/works/10.1046/J.1468-2982.2003.00525.X

Indomethacin and acetylsalicylic acid block neurogenic plasma protein extravasation in rat dura mater

14 March 2024

35

1 reference

https://api.crossref.org/works/10.1046/J.1468-2982.2003.00525.X

Neurogenically Mediated Plasma Extravasation in Dura Mater: Effect of Ergot Alkaloids: A Possible Mechanism of Action in Vascular Headache

14 March 2024

36

1 reference

https://api.crossref.org/works/10.1046/J.1468-2982.2003.00525.X

Vasoactive peptide release in the extracerebral circulation of humans during migraine headache

14 March 2024

38

1 reference

https://api.crossref.org/works/10.1046/J.1468-2982.2003.00525.X

Vasoactive peptide levels in the plasma of young migraine patients with and without aura assessed both interictally and ictally

14 March 2024

39

1 reference

https://api.crossref.org/works/10.1046/J.1468-2982.2003.00525.X

Evidence for increased plasma levels of calcitonin gene-related peptide in migraine outside of attacks

14 March 2024

40

1 reference

https://api.crossref.org/works/10.1046/J.1468-2982.2003.00525.X

The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats.

14 March 2024

41

1 reference

https://api.crossref.org/works/10.1046/J.1468-2982.2003.00525.X

Endothelin antagonist bosentan blocks neurogenic inflammation, but is not effective in aborting migraine attacks

14 March 2024

43

1 reference

https://api.crossref.org/works/10.1046/J.1468-2982.2003.00525.X

Ineffectiveness of neurokinin-1 antagonist in acute migraine: a crossover study

14 March 2024

45

1 reference

https://api.crossref.org/works/10.1046/J.1468-2982.2003.00525.X

Acute treatments: some blind alleys

14 March 2024

46

1 reference

https://api.crossref.org/works/10.1046/J.1468-2982.2003.00525.X

Retinal plasma extravasation in animals but not in humans: implications for the pathophysiology of migraine

14 March 2024

47

1 reference

https://api.crossref.org/works/10.1046/J.1468-2982.2003.00525.X

Characterization of LY344864 as a pharmacological tool to study 5-HT1F receptors: Binding affinities, brain penetration and activity in the neurogenic dural inflammation model of migraine

14 March 2024

48

1 reference

https://api.crossref.org/works/10.1046/J.1468-2982.2003.00525.X

Human 5-HT1F receptor-stimulated [35S]GTPgammaS binding: correlation with inhibition of guinea pig dural plasma protein extravasation

14 March 2024

49

1 reference

https://api.crossref.org/works/10.1046/J.1468-2982.2003.00525.X

G-protein activation at 5-HT1A receptors by the 5-ht1F ligand LY334370 in guinea-pig brain sections and recombinant cell lines

14 March 2024

50

1 reference

https://api.crossref.org/works/10.1046/J.1468-2982.2003.00525.X

5-HT(1A) and 5-HT(1B/1D) receptors are involved in the modulation of the trigeminovascular system of the cat: a microiontophoretic study

14 March 2024

51

1 reference

https://api.crossref.org/works/10.1046/J.1468-2982.2003.00525.X

Selective seratonin 1F (5-HT(1F)) receptor agonist LY334370 for acute migraine: a randomised controlled trial

14 March 2024

58

1 reference

https://api.crossref.org/works/10.1046/J.1468-2982.2003.00525.X

Receptor specificity and trigemino-vascular inhibitory actions of a novel 5-HT1B/1D receptor partial agonist, 311C90 (zolmitriptan).

14 March 2024

60

1 reference

https://api.crossref.org/works/10.1046/J.1468-2982.2003.00525.X

The anti-migraine 5-HT(1B/1D) agonist rizatriptan inhibits neurogenic dural vasodilation in anaesthetized guinea-pigs

14 March 2024

61

1 reference

https://api.crossref.org/works/10.1046/J.1468-2982.2003.00525.X

Serotonin inhibits trigeminal nucleus activity evoked by craniovascular stimulation through a 5HT1B/1D receptor: a central action in migraine?

14 March 2024

63

1 reference

https://api.crossref.org/works/10.1046/J.1468-2982.2003.00525.X

14 March 2024

Identifiers

1 reference

3 August 2017

1 reference